Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$13.84 - $17.8 $973,035 - $1.25 Million
-70,306 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$12.4 - $17.6 $302,039 - $428,700
-24,358 Reduced 25.73%
70,306 $1.06 Million
Q3 2020

Nov 16, 2020

SELL
$11.59 - $14.93 $62,470 - $80,472
-5,390 Reduced 5.39%
94,664 $1.25 Million
Q2 2020

Aug 07, 2020

SELL
$11.79 - $15.97 $195,124 - $264,303
-16,550 Reduced 14.19%
100,054 $1.25 Million
Q4 2019

Feb 14, 2020

SELL
$13.91 - $21.48 $162,009 - $250,177
-11,647 Reduced 9.08%
116,604 $2.33 Million
Q2 2019

Aug 14, 2019

BUY
$17.38 - $26.88 $2.23 Million - $3.45 Million
128,251 New
128,251 $3.45 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $181M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Hhr Asset Management, LLC Portfolio

Follow Hhr Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhr Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hhr Asset Management, LLC with notifications on news.